Alessandro Armuzzi (A Armuzzi, Alessandro Armuzi)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 44

Top Topics

Ankylosing Spondylitis

Ulcerative Colitis

Patients With Inflammatory Bowel Disease

Computed Tomography

Top Venues

Journal of clinical medicine

Alimentary pharmacology & therapeutics

International journal of molecular sciences

Inflammatory bowel diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Bianca Bartocci, Arianna Dal Buono, Roberto Gabbiadini, Anita Busacca, Alessandro Quadarella, Alessandro Repici, Emanuela Mencaglia, Linda Gasparini, Alessandro Armuzzi
Mental Illnesses in Inflammatory Bowel Diseases: mens sana in corpore sano . Medicina (Kaunas, Lithuania) 59 (4) (2023)
Carla Felice, Arianna Dal Buono, Roberto Gabbiadini, Marcello Rattazzi, Alessandro Armuzzi
Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications. International journal of molecular sciences 24 (4) (2023)
Giulia Rizzo, Samuel Elias Pineda Chavez, Elisa Vandenkoornhuyse, Cindy Lorena Cárdenas Rincón, Valeria Cento, Valentina Garlatti, Marek Wozny, Giusy Sammarco, Alessia Di Claudio, Lisa Meanti, Sudharshan Elangovan, Andrea Romano, Giulia Roda, Laura Loy, Arianna Dal Buono, Roberto Gabbiadini, Sara Lovisa, Roberto Rusconi, Alessandro Repici, Alessandro Armuzzi, Stefania Vetrano
Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal Fibroblasts. Nutrients 15 (7) (2023)
Bianca Bartocci, Arianna Dal Buono, Roberto Gabbiadini, Anita Busacca, Alessandro Quadarella, Alessandro Repici, Emanuela Mencaglia, Linda Gasparini, Alessandro Armuzzi
Mental Illnesses in Inflammatory Bowel Diseases: mens sana in corpore sano . Medicina (Kaunas, Lithuania) 59 (4) (2023)
Tommaso Lorenzo Parigi, Rosanna Cannatelli, Olga Maria Nardone, Irene Zammarchi, Uday Shivaji, Federica Furfaro, Davide Zardo, Paola Spaggiari, Rachele Del Sordo, Orsola Setti, Snehali Majumder, Samuel Charles Lloyd Smith, Silvio Danese, Alessandro Armuzzi, Vincenzo Villanacci, Subrata Ghosh, Marietta Iacucci
Neutrophil-only histological assessment of ulcerative colitis correlates with endoscopic activity and predicts long-term outcomes in a multicenter study. Journal of Crohn's & colitis (2023)
Bianca Bartocci, Arianna Dal Buono, Roberto Gabbiadini, Anita Busacca, Alessandro Quadarella, Alessandro Repici, Emanuela Mencaglia, Linda Gasparini, Alessandro Armuzzi
Mental Illnesses in Inflammatory Bowel Diseases: mens sana in corpore sano . Medicina (Kaunas, Lithuania) 59 (4) (2023)
Laura Maria Minordi, Luigi Larosa, Maria Gabriella Brizi, Alessandro Armuzzi, Riccardo Manfredi
Length of the healthy and pathological small intestine in patients with Crohn's disease: calculations using computed tomography and magnetic resonance enterography. Diagnostic and interventional radiology (Ankara, Turkey) 29 (1) (2023)
Alessandro Armuzzi, Ailsa L Hart, Joseph Christopher Cappelleri, Nadir Mammar, Peter Hur, Benjamin Hoskin, Fritha Hennessy, Gary Milligan, Axel U Dignass
Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries. BMC gastroenterology 23 (1) (2023)
Carla Felice, Arianna Dal Buono, Roberto Gabbiadini, Marcello Rattazzi, Alessandro Armuzzi
Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications. International journal of molecular sciences 24 (4) (2023)
Giuseppe Privitera, Nitish Rana, Alessandro Armuzzi, Theresa T Pizarro
The gasdermin protein family: emerging roles in gastrointestinal health and disease. Nature reviews. Gastroenterology & hepatology (2023)
Ahmad Albshesh, Lian Bannon, Tali Sharar Fischler, Marie Truyens, Stephan R Vavricka, Katja Tepes, Daniela Pugliese, Edoardo Vincenzo Savarino, Eran Zittan, David Drobne, Xavier Roblin, Ariella Bar-Gil Shitrit, Alessandro Armuzzi, Triana Lobaton, Nitsan Maharshak, Henit Yanai, Shomron Ben-Horin, Uri Kopylov
Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn's Disease: A Multi-Center Retrospective Cohort Study. Journal of clinical medicine 12 (7) (2023)
Carla Felice, Arianna Dal Buono, Roberto Gabbiadini, Marcello Rattazzi, Alessandro Armuzzi
Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications. International journal of molecular sciences 24 (4) (2023)
Tamás Resál, Péter Bacsur, Csilla Keresztes, Anita Bálint, Renáta Bor, Anna Fábián, Bernadett Farkas, Kostas Katsanos, George Michalopoylos, Davide Giuseppe Ribaldone, Mohamed Attauabi, Mirabella Zhao, Hadar Amir Barak, Henit Yanai, Cristina Bezzio, Antonio Rispo, Fabiana Castiglione, Ariella Bar-Gil Shitrit, Daniela Pugliese, Alessandro Armuzzi, Edoardo Vincenzo Savarino, Martin Kolar, Milan Lukáš, Elena Chashkova, Rafał Filip, Aurore Rozieres, Stéphane Nancey, Željko Krznarić, Eszter Schäfer, null Szamosi, Patrícia Sarlós, Matej Franko, David Drobne, Oleg V Knyazev, Anna V Kagramanova, Jimmy Limdi, Panu Wetwittayakhlang, Peter L Lakatos, Nitsan Maharshak, Lian Bannon, Tibor Nyári, Zoltán Szepes, Klaudia Farkas, null null, Tamás Molnár
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study. Inflammatory bowel diseases (2023)
Virginia Solitano, Arianna Dal Buono, Roberto Gabbiadini, Marek Wozny, Alessandro Repici, Antonino Spinelli, Stefania Vetrano, Alessandro Armuzzi
Fibro-Stenosing Crohn's Disease: What Is New and What Is Next? Journal of clinical medicine 12 (9) (2023)
Virginia Solitano, Arianna Dal Buono, Roberto Gabbiadini, Marek Wozny, Alessandro Repici, Antonino Spinelli, Stefania Vetrano, Alessandro Armuzzi
Fibro-Stenosing Crohn's Disease: What Is New and What Is Next? Journal of clinical medicine 12 (9) (2023)
Bianca Bartocci, Arianna Dal Buono, Roberto Gabbiadini, Anita Busacca, Alessandro Quadarella, Alessandro Repici, Emanuela Mencaglia, Linda Gasparini, Alessandro Armuzzi
Mental Illnesses in Inflammatory Bowel Diseases: mens sana in corpore sano . Medicina (Kaunas, Lithuania) 59 (4) (2023)
Carla Felice, Arianna Dal Buono, Roberto Gabbiadini, Marcello Rattazzi, Alessandro Armuzzi
Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications. International journal of molecular sciences 24 (4) (2023)
Alessandro Armuzzi, Ailsa L Hart, Joseph Christopher Cappelleri, Nadir Mammar, Peter Hur, Benjamin Hoskin, Fritha Hennessy, Gary Milligan, Axel U Dignass
Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries. BMC gastroenterology 23 (1) (2023)
Arianna Dal Buono, Alessandro Armuzzi
Transperineal Ultrasonography in the Assessment of Rectal Inflammation: Beyond the Monitoring of Ulcerative Colitis. Inflammatory bowel diseases (2023)
Carolina Aliai Micol Cavalli, Roberto Gabbiadini, Arianna Dal Buono, Alessandro Quadarella, Alessandro De Marco, Alessandro Repici, Cristina Bezzio, Edoardo Simonetta, Stefano Aliberti, Alessandro Armuzzi
Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections. Journal of clinical medicine 12 (19) (2023)
Maria Terrin, Giulia Migliorisi, Arianna Dal Buono, Roberto Gabbiadini, Elisabetta Mastrorocco, Alessandro Quadarella, Alessandro Repici, Armando Santoro, Alessandro Armuzzi
Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management. International journal of molecular sciences 24 (14) (2023)
Laurent Peyrin Biroulet, Severine Vermeire, Geert D'Haens, Julian Panes, Axel U Dignass, Fernando Magro, Maciej Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Ivana Bravatà, Frederic Lavie, Marco Daperno, Milan Lukáš, Alessandro Armuzzi, Mark Löwenberg, Daniel R Gaya, Silvio Danese
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST. Alimentary pharmacology & therapeutics (2023)
Alessandro Armuzzi, Ailsa L Hart, Joseph Christopher Cappelleri, Nadir Mammar, Peter Hur, Benjamin Hoskin, Fritha Hennessy, Gary Milligan, Axel U Dignass
Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries. BMC gastroenterology 23 (1) (2023)
Antonio Tursi, Giammarco Mocci, Leonardo Allegretta, Giovanni Aragona, Maria Antonia Bianco, Raffaele Colucci, Antonio Cuomo, Nicola Della Valle, Antonio Ferronato, Giacomo Forti, Federica Gaiani, GianMarco Giorgetti, Maria Giovanna Graziani, Katia Lofano, Roberto Lorenzetti, Tiziana Larussa, Antonio Penna, Roberta Pica, Giuseppe Pranzo, Stefano Rodino', Antonella Scarcelli, Costantino Zampaletta, Gabrio Bassotti, Alessia Immacolata Cazzato, Stefania Chiri, Valeria Clemente, Andrea Cocco, Gianluigi De' Angelis, Laura Donnarumma, Roberto Faggiani, Camilla Graziosi, Marco Le Grazie, Francesco Luzza, Costantino Meucci, Rita Monterubbianesi, Cristiano Pagnini, Patrizia Perazzo, Marcello Picchio, Rodolfo Sacco, Ladislava Sebkova, Mariaelena Serio, Daniele Napolitano, Daniela Pugliese, Franco Scaldaferri, Elisa Schiavoni, Laura Turchini, Alessandro Armuzzi, Walter Elisei, Giovanni Maconi, Alfredo Papa
Comparison of Performances of Adalimumab Biosimilars SB5, APB501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study. Inflammatory bowel diseases (2022)
Daniela Pugliese, Giuseppe Privitera, Alessandro Armuzzi
Editorial: effectiveness and safety of vedolizumab in a matched cohort of elderly and non-elderly patients with inflammatory bowel disease-the IG-IBD LIVE study. Authors' reply. Alimentary pharmacology & therapeutics 56 (4) (2022)
Daniela Pugliese, Sara Onali, Giuseppe Privitera, Alessandro Armuzzi, Claudio Papi
Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies. Journal of clinical medicine 11 (22) (2022)
Daniela Pugliese, Giuseppe Privitera, Luigi Larosa, Valentin Calvez, Diana Broglia, Nicoletta de Matthaeis, Alessandro Armuzzi
A rare case of epiploic appendagitis in a patient affected by ulcerative colitis on vedolizumab therapy. Gastroenterology report 10 (2022)
Daniela Pugliese, Giuseppe Privitera, Marcello Fiorani, Laura Parisio, Valentin Calvez, Alfredo Papa, Antonio Gasbarrini, Alessandro Armuzzi
Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab. Therapeutic advances in gastroenterology 15 (2022)
Alessandro Armuzzi, Daniela Pugliese
Hyperbaric oxygen therapy: More hope than hype for future treatment of perianal fistulizing Crohn's disease? United European gastroenterology journal 10 (2) (2022)
Giuseppe Privitera, Daniela Pugliese, Alessandro Armuzzi, Luisa Guidi
Dual Targeted Therapy in Patient With Extensive Crohn's Disease: Different Response at Distinct Location. Inflammatory bowel diseases 27 (8) (2022)
Daniela Pugliese, Giuseppe Privitera, Federica Crispino, Nicolò Mezzina, Fabiana Castiglione, Gionata Fiorino, Lucrezia Laterza, Anna Viola, Lorenzo Bertani, Flavio Caprioli, Maria Cappello, Brigida Barberio, Chiara Ricci, Paola Balestrieri, Marco Daperno, Dario Pluchino, Fernando Rizzello, Maria Lia Scribano, Renato Sablich, Luca Pastorelli, Francesco Manguso, Angela Variola, Antonio Di Sario, Laurino Grossi, Alessandro Armuzzi, null null
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study. Alimentary pharmacology & therapeutics 56 (1) (2022)
Virginia Solitano, Alessandro Armuzzi
Editorial: STAT3 phosphorylation for tofacitinib monitoring in ulcerative colitis-a step towards precision medicine? Alimentary pharmacology & therapeutics 56 (2) (2022)
Rocco Spagnuolo, Alessandro Corea, Daniele Napolitano, Eleonora Nisticò, Raffaele Pagnotta, Caterina Pagliuso, Elisa Schiavoni, Laura Turchini, Gionata Fiorino, Simona Radice, Alessandro Armuzzi, Patrizia Doldo
Nursing-sensitive outcomes in adult inflammatory bowel disease: A systematic review. Journal of advanced nursing 77 (5) (2021)
Giuseppe Privitera, Daniela Pugliese, Gian Ludovico Rapaccini, Antonio Gasbarrini, Alessandro Armuzzi, Luisa Guidi
Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases. Journal of clinical medicine 10 (4) (2021)
Alfredo Cesario, Marika D'Oria, Francesco Bove, Giuseppe Privitera, Guido Costamagna, Daniela Pedicino, Luca Boldrini, Carmen Erra, Claudia Loreti, Giovanna Liuzzo, Filippo Crea, Alessandro Armuzzi, Antonio Gasbarrini, Paolo Calabresi, Luca Padua, Guido Costamagna, Massimo Antonelli, Vincenzo Valentini, Charles Auffray, Giovanni Scambia
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence. Journal of personalized medicine 11 (4) (2021)
Giuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso, Franco Scaldaferri, Matteo Neri, Luisa Guidi, Antonio Gasbarrini, Alessandro Armuzzi
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches. Therapeutic advances in gastroenterology 14 (2021)
Giuseppe Privitera, Daniela Pugliese, Franco Scaldaferri, Alessandro Armuzzi
Letter: SARS-CoV-2 infection in two IBD patients treated with dual targeted therapy. Alimentary pharmacology & therapeutics 53 (6) (2021)
Claudio Fiorillo, Carlo Alberto Schena, Giuseppe Quero, Vito Laterza, Daniela Pugliese, Giuseppe Privitera, Fausto Rosa, Tommaso Schepis, Lisa Salvatore, Brunella Di Stefano, Luigi Larosa, Laura Maria Minordi, Luigi Natale, Giampaolo Tortora, Alessandro Armuzzi, Sergio Alfieri
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis. Cancers 13 (3) (2021)
Daniela Pugliese, Alessandro Armuzzi
Editorial: withdrawal of anti TNF-alpha - are we ready for biological therapy cycling? Alimentary pharmacology & therapeutics 54 (1) (2021)
Matteo Ruggeri, Carlo Drago, Chiara Cadeddu, Alessandro Armuzzi, Salvatore Leone, Marco Marchetti
The Determinants of Out-of-Pocket Expenditure in IBD Italian Patients. Results from the AMICI Survey. International journal of environmental research and public health 17 (21) (2020)
Giuseppe Pietropaolo, Daniela Pugliese, Alessandro Armuzzi, Luisa Guidi, Antonio Gasbarrini, Gian Lodovico Rapaccini, Federica I Wolf, Valentina Trapani
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy. Nutrients 12 (11) (2020)
C Felice, P Leccese, L Scudeller, E Lubrano, F Cantini, F Castiglione, P Gionchetti, A Orlando, C Salvarani, R Scarpa, M Vecchi, I Olivieri, Alessandro Armuzzi, null null
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis. Clinical and experimental immunology 196 (1) (2019)
Marco Daperno, Alessandro Armuzzi, Silvio Danese, Walter Fries, Giuseppina Liguori, Ambrogio Orlando, Claudio Papi, Mariabeatrice Principi, Fernando Rizzello, Angelo Viscido, Paolo Gionchetti
Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus. Gastroenterology research and practice 2019 (2019)
Daniela Pugliese, Annalisa Aratari, Stefano Festa, Pietro Manuel Ferraro, Rita Monterubbianesi, Luisa Guidi, Maria Lia Scribano, Claudio Papi, Alessandro Armuzzi
Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study. Gastroenterology research and practice 2018 (2018)